Risk of nephrolithiasis associated with SGLT2 inhibitors versus DPP4 inhibitors among patients with type 2 diabetes: a target trial emulation study
Shin A, Shin JY, Kang EH
Diabetes Care. 2024:dc241652.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Shin A, Shin JY, Kang EH
Diabetes Care. 2024:dc241652.
Leggi
Kao DP, Martin JL, Aquilante CL, et al.
BMJ Open Diabetes Res Care. 2024;12(6):e004343.
Leggi
de Vries ST, Pena MJ, Tye SC, et al.
Diabetologia. Pub. online 10 Dec 2024.
Leggi
Yu D, Fu H, Zhao Z, et al.
BMJ Open Diabetes Res Care. 2024;12(6):e004210.
Leggi
Ohkuma T, Harris K, Woodward M, et al.
Diabetes Care. 2024:dc241516.
Leggi
Askø Andersen J, Rasmussen A, Engberg S, et al.
BMJ Open Diabetes Res Care. 2024;12(6):e004398.
Leggi
Pham CT, Ali A, Churilov L, et al.
Diabet Med. 2024:e15485.
Leggi
Bao Y, Hu Y, Shi M, Zhao Z
Diabetes Obes Metab. Pub. online 6 Dec 2024.
Leggi
Golubic R, Mumbole H, Ismail MH, et al.
Diabet Med. 2024:e15475.
Leggi
Wen J, Razick A, How-Volkman C, et al.
Diabetes Obes Metab. Pub. online 9 Dec 2024.
Leggi